Levosalbutamol

# Levosalbutamol ## Overview - **Classification**: Short-acting beta-2 adrenergic agonist (SABA) - **Mechanism**: Selectively stimulates beta-2 adrenergic receptors in bronchial smooth muscle, leading to relaxation and bronchodilation. ## Primary Indications 1. **Bronchospasm**: For relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. 2. **Exercise-Induced Bronchospasm**: Prevention of exercise-induced bronchospasm. ## Adult Dosing ### Standard Dosing **Bronchospasm (Inhalation Solution)** - **Dose**: **0.63 mg** or **1.25 mg** - **Frequency**: Three times a day (every 6-8 hours) - **Route**: Via nebulization - **Duration**: As needed for symptom relief **Bronchospasm (Metered-Dose Inhaler - MDI)** - **Dose**: **90 mcg** (2 inhalations) - **Frequency**: Every 4-6 hours as needed - **Route**: Oral inhalation - **Maximum Dose**: Do not exceed **90 mcg** every 4 hours. ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment guidelines. Use with caution in severe renal impairment; monitor for adverse effects. - **Hepatic Impairment**: No specific dose adjustment guidelines. Use with caution; monitor for adverse effects. - **Elderly Patients**: Consider starting at the lower dose (**0.63 mg** nebulizer) due to potential increased sensitivity and comorbidities. ## Pediatric Dosing ### Neonates (0-28 days) - **Note**: Not recommended for this age group due to limited safety and efficacy data, and increased risk of cardiovascular effects. ### Infants (1-12 months) - **Dose**: **0.31 mg** - **Frequency**: Three times a day (every 6-8 hours) - **Route**: Via nebulization - **Maximum**: **0.63 mg** three times a day, if clinically indicated and tolerated. - **Special Notes**: Monitor closely for tachycardia, tremor. Ensure proper nebulizer mask fit. ### Children (1-12 years) **Bronchospasm (Inhalation Solution)** - **Dose (4-11 years)**: **0.31 mg** to **0.63 mg** - **Frequency**: Three times a day (every 6-8 hours) - **Route**: Via nebulization - **Maximum**: **1.25 mg** three times a day. **Bronchospasm (MDI)** - **Dose (4-11 years)**: **45 mcg** (1 inhalation) - **Frequency**: Every 4-6 hours as needed; may increase to **90 mcg** (2 inhalations) - **Route**: Oral inhalation (with spacer/holding chamber recommended) - **Maximum**: **90 mcg** (2 inhalations) every 4 hours. ### Adolescents (13-18 years) - **Dose**: Refer to adult dosing. - **Maximum**: As per adult maximums. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to levosalbutamol or any component. - **Absolute**: Known hypersensitivity to racemic albuterol. ### Common Adverse Effects - **Very Common (>10%)**: Pharyngitis, rhinitis - **Common (1-10%)**: Tremor, nervousness, headache, dizziness, tachycardia, cough, vomiting, pain. - **Serious but Rare**: Paradoxical bronchospasm (discontinue immediately), severe hypokalemia, cardiac arrest, arrhythmias. ### Key Drug Interactions - **Beta-blockers (non-selective)**: May block bronchodilatory effect and cause severe bronchospasm. Avoid concomitant use. - **Diuretics (non-potassium sparing)**: May potentiate hypokalemia and ECG changes. Monitor serum potassium. - **MAOIs & TCAs**: May potentiate cardiovascular effects (e.g., increased heart rate, blood pressure). Use with extreme caution. - **Other Sympathomimetics**: Increased risk of cardiovascular adverse effects. ## Monitoring & Follow-up - **Before Treatment**: Assess baseline pulmonary function (FEV1/PEFR), heart rate, blood pressure. - **During Treatment**: Monitor frequency of rescue inhaler use, symptom control, heart rate, blood pressure. - **Clinical Signs**: Watch for worsening asthma symptoms, increased need for medication, signs of adverse effects (e.g., tremor, palpitations). - **Periodic**: Serum potassium (if at risk for hypokalemia), blood glucose (in diabetic patients). ## Clinical Pearls - 💡 **R-isomer Advantage**: Levosalbutamol is the single R-isomer of albuterol, potentially offering similar efficacy with a lower incidence of some side effects (e.g., tremor, nervousness). - 💡 **Rescue Use Only**: Levosalbutamol is a rescue medication for acute symptoms; it is not for long-term maintenance or chronic daily use. - 💡 **Proper Technique**: Ensure patients are educated on correct nebulizer or MDI technique, including the use of a spacer for MDIs. - 💡 **Overuse Warning**: Increased use of rescue inhalers indicates worsening asthma control and requires re-evaluation of the treatment plan. - 💡 **Exercise Prevention**: Inhale 15-30 minutes before exercise for prevention of exercise-induced bronchospasm. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.